BITTO, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 19.161
NA - Nord America 18.750
AS - Asia 9.803
SA - Sud America 3.170
Continente sconosciuto - Info sul continente non disponibili 818
AF - Africa 308
OC - Oceania 20
Totale 52.030
Nazione #
US - Stati Uniti d'America 18.312
RU - Federazione Russa 9.398
SG - Singapore 4.063
CN - Cina 2.882
BR - Brasile 2.747
IE - Irlanda 2.206
SE - Svezia 1.947
IT - Italia 1.632
HK - Hong Kong 1.068
DE - Germania 849
UA - Ucraina 578
FR - Francia 572
PL - Polonia 567
VN - Vietnam 538
GB - Regno Unito 476
FI - Finlandia 466
IN - India 285
CA - Canada 182
BD - Bangladesh 148
AR - Argentina 136
MX - Messico 134
TR - Turchia 99
ID - Indonesia 96
BE - Belgio 90
ZA - Sudafrica 83
IQ - Iraq 80
AT - Austria 79
JP - Giappone 66
EC - Ecuador 64
ES - Italia 64
CO - Colombia 59
MA - Marocco 59
KR - Corea 58
PK - Pakistan 56
VE - Venezuela 55
NL - Olanda 52
CI - Costa d'Avorio 50
UZ - Uzbekistan 47
CZ - Repubblica Ceca 40
CL - Cile 38
IR - Iran 31
AE - Emirati Arabi Uniti 26
CR - Costa Rica 26
PH - Filippine 26
KE - Kenya 24
PY - Paraguay 24
JO - Giordania 23
UY - Uruguay 23
MY - Malesia 22
EG - Egitto 20
JM - Giamaica 19
LT - Lituania 19
TN - Tunisia 19
NP - Nepal 18
AU - Australia 17
DO - Repubblica Dominicana 17
OM - Oman 17
IL - Israele 16
SA - Arabia Saudita 16
AZ - Azerbaigian 15
DZ - Algeria 13
AL - Albania 12
KG - Kirghizistan 12
PA - Panama 12
RO - Romania 12
TH - Thailandia 12
BO - Bolivia 11
LV - Lettonia 11
CH - Svizzera 10
GE - Georgia 10
PE - Perù 10
BG - Bulgaria 9
HN - Honduras 9
KZ - Kazakistan 9
LB - Libano 9
NI - Nicaragua 9
RS - Serbia 9
EU - Europa 8
PT - Portogallo 8
QA - Qatar 8
BA - Bosnia-Erzegovina 7
SN - Senegal 7
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
ET - Etiopia 6
GT - Guatemala 6
HU - Ungheria 6
KH - Cambogia 6
BN - Brunei Darussalam 5
DK - Danimarca 5
EE - Estonia 5
GR - Grecia 5
LU - Lussemburgo 5
MU - Mauritius 5
NO - Norvegia 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
AO - Angola 4
BY - Bielorussia 4
Totale 51.151
Città #
Ashburn 2.867
Moscow 2.763
Singapore 2.274
Dublin 2.204
Dallas 2.089
Chandler 1.564
Jacksonville 1.224
Hong Kong 1.062
Nyköping 966
San Jose 922
Beijing 911
Messina 651
Council Bluffs 541
Warsaw 540
The Dalles 481
Los Angeles 401
Dearborn 374
Princeton 360
Medford 332
Lauterbourg 330
Ann Arbor 325
Cambridge 322
New York 265
Boardman 249
Des Moines 248
Munich 244
São Paulo 213
Ho Chi Minh City 182
Buffalo 177
Wilmington 142
Tianjin 140
Lancaster 136
Santa Clara 136
Hanoi 117
Rome 114
Woodbridge 110
Guangzhou 104
Jinan 99
Shenyang 98
Frankfurt am Main 97
Orem 95
Redondo Beach 90
Houston 87
Brussels 86
San Mateo 85
Rio de Janeiro 81
Turku 78
Atlanta 77
Belo Horizonte 71
Hyderabad 64
Pune 63
Montreal 61
Jakarta 59
Nanjing 59
Helsinki 58
Columbus 57
Seattle 57
Brasília 56
Hebei 56
Brooklyn 54
Tokyo 54
Curitiba 52
Abidjan 50
Johannesburg 49
Vienna 48
Chennai 47
Denver 47
Phoenix 47
Shanghai 47
Zhengzhou 47
Bremen 46
Stockholm 46
London 45
Boston 44
Haikou 44
Ningbo 44
Tashkent 43
Dong Ket 42
Porto Alegre 42
Nuremberg 40
Taizhou 39
Chicago 38
Washington 38
San Francisco 37
Falls Church 35
Ottawa 34
Shenzhen 33
Toronto 33
Campinas 32
Mexico City 32
Milan 32
Manchester 31
Salvador 31
Baghdad 30
Amsterdam 29
Hangzhou 29
Brno 28
Poplar 28
Guarulhos 26
Goiânia 25
Totale 29.332
Nome #
Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. 358
Oxidative Stress: Harms and Benefits for Human Health 348
Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds 313
Activation of A2A receptor by PDRN Reduces neuronal damage and stimulates WNT/β-CATENIN driven neurogenesis in spinal cord injury 310
A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury. 305
Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study 277
Activation of adenosine A2(A) receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice 276
Imbalance of serum cytokine network in sarcoid patients: index of sarcoidosis relapse? 275
Dietary management of skin health: The role of genistein 272
Pharmacological activity and clinical use of PDRN 267
Combined treatment with polynucleotides and hyaluronic acid improves tissue repair in experimental colitis 260
Correlations between genetic mutations, biomolecular patterns and elastic properties of the aorta in patients with bicuspid aortic valve. 259
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 256
Activation of the EPOR-β common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes 254
2017 ACR/ARHP Annual Meeting Abstract Supplement 253
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 247
Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model 247
IRFI 042 reduces oxidative stress against kainic acid toxicity in the rat brain. 244
Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury 244
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 244
A NEW MELANOCORTIN AGONIST REDUCES CERULEIN INDUCED PANCREATIC DAMAGE IN AN EXPERIMENTAL RAT MODEL 242
Activation of adenosine A2A receptors by polydeoxyribonucleotide increases vascular endothelial growth factor and protects against testicular damage induced by experimental varicocele in rats. 242
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 241
PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation 241
Blockade of the JNK signalling as a rational therapeutic approach to modulate the early and late steps of the inflammatory cascade in polymicrobial sepsis 236
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappa B activation, blunts TNF-alpha production, and protects against splanchnic artery occlusion shock 231
Medical simulation in pharmacology learning and retention: A comparison study with traditional teaching in undergraduate medical students 230
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 229
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients 225
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 223
Evidence for a role of mitogen-activated protein kinases in the treatment of experimental acute pancreatitis. 222
ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury 219
Adapted physical activity for breast cancer patients: shared considerations with two Olympic and world Italian sports champions 215
Role of Inhibitors of Apoptosis Proteins in Testicular Function and Male Fertility: Effects of Polydeoxyribonucleotide Administration in Experimental Varicocele 213
β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors 211
A 1-year study on hydroxy-methylglutaryl coenzymea reductase gene expression and polymorphisms in hypercholesterolemic treated with statins. 209
CO2 Pneumoperitoneum Preserves -Arrestin 2 Content and Reduces High Mobility Group Box-1 (HMGB-1) Expression in an Animal Model of Peritonitis 209
Angiopoietin-1 gene transfer improves the impaired wound healing of the genetically diabetic mice without increasing VEGF expression. 208
Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway. 208
AB0197 Simvastatin Attenuates Aortic Thickness in the Chronic Reactive Oxygen Species Murine Model of Systemic Sclerosis 208
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 207
Effects of polydeoxyribonucleotide on the histological damage and the altered spermatogenesis induced by testicular ischaemia and reperfusion in rats 207
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 205
CO(2) pneumoperitoneum impact on early liver and lung cytokine expression in a rat model of abdominal sepsis. 205
Cadmium-induced oxidative stress impairs glycemic control in adolescents 205
Effects of polydeoxiribonucleotide on the histological damage and altered spermatogenesis induced by tresticular ischemia and reperfusion in rats 201
Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians 200
C-Reactive Protein (CRP) plasma levels, monocyte MCP-1 (Monocyte Chemoattractant Protein-1) and TF (Tissue Factor) mRNA in patients with primary arterial hypertension 199
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 197
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 197
Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice 196
Anti-Inflammatory Effects of the Methanol Extract of Sedum telephium ssp maximum in Lipopolysaccharide-Stimulated Rat Peritoneal Macrophages 195
ADENOSINE RECEPTOR STIMULATION BY POLYDEOXYRIBONUCLEOTIDE ACTIVATES CELL CYCLE AND IMPROVES SKIN HEALING IN THE GENETICALLY DIABETIC MOUSE. 195
Polyethylene glycol formulations show different soft tissue remodelling and angiogenesis features. 194
Cadmium delays puberty onset and testis growth in adolescents 194
High mobility group box-1 expression correlates with poor outcome in lung injury patients. 193
Biglycan Involvement in Heart Fibrosis: Modulation of Adenosine 2A Receptor Improves Damage in Immortalized Cardiac Fibroblasts 191
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 191
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 191
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 189
Bicuspid aortic valve and aortopathy: novel prognostic predictors for the identification of high-risk patients 189
Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury 189
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 188
Anti-oxidant and anti-inflammatory effects of ellagic and punicic acid in an in vitro model of cardiac fibrosis 187
Adenosine receptor stimulation by polynucleotides (PDRN) reduces inflammation in experimental periodontitis. 187
Elastin and aortopathy in bicuspid aortic valve: correlations between genetic and biomolecular patterns and mechanical properties of the aorta 187
Impairment of elastic properties of the aorta in bicuspid aortic valve: relationship between biomolecular and aortic strain patterns 187
Biglycan expression is increased in hypertensive subjects with normal or increased carotid intima-media wall thickness 186
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 185
Polydeoxyribonucleotide, an adenosine-A2A receptor agonist, preserves blood testis barrier from cadmium-induced injury 185
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 185
Mitogen-activated protein kinase 3/mitogen-activated protein kinase 1 activates apoptosis during testicular ischemia-reperfusion injury in a nuclear factor-kappaB-independent manner. 183
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 181
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 181
Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages 180
Flavocoxid, a nutraceutical approach to blunt inflammatory conditions. 179
Peroxisome proliferator activated receptor beta/delta activation prevents extracellular regulated kinase 1/2 phosphorylation and protects the testis from ischemia and reperfusion injury. 178
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness 178
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 178
Correct management and low rate of contagiousness of healthcare workers in a university hospital in Southern Italy: From contact tracing to serological investigation 178
Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate 175
Serum cytokine dysregulation in multiple sclerosis patients 174
COULD SERUM LEVELS OF MCP-1, IL-12, IFN-gamma and TNF-alpha BE PREDICTIVE OF SARCOIDOSIS RELAPSE? 174
Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease 174
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 173
EFFECTS OF PDRN ON SPERMATOGENETIC ACTIVITY DURING THE PROGRESSION OF TESTICULAR ISCHEMIA AND REPERFUSION IN RATS 173
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 172
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 172
Utilizzo della istradefillina per ridurre la fibrosi d’organo 171
Cardiovascular effects of the phytoestrogen genistein 170
Composition based on genistein for the treatment of obesity 168
Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate 167
Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis. 167
Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(2A) receptor 167
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 167
Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury 166
AB0198 Cilengitide Modulates Pulmonary Cell Proliferation in the Reactive Oxygen Species Murine Model of Systemic Sclerosis 166
Correction: Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis 166
Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet 165
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 165
Totale 20.986
Categoria #
all - tutte 173.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.696 0 365 61 104 141 43 195 114 54 509 309 801
2022/20236.219 486 539 289 437 460 618 67 362 2.657 25 192 87
2023/20241.973 111 233 143 222 169 380 64 52 5 266 94 234
2024/20257.830 156 72 124 554 386 312 175 1.684 1.937 453 730 1.247
2025/202623.757 1.150 1.711 2.043 1.499 1.928 4.848 2.860 2.801 2.877 1.150 413 477
2026/20272.095 517 1.578 0 0 0 0 0 0 0 0 0 0
Totale 52.030